Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee advances ‘right to try’ bill to let some patients seek individualized investigational therapies
Summary
The Senate Health & Human Services Committee voted unanimously to send House Bill 25 12 70 — which would allow eligible patients to pursue individualized investigational medical treatments not yet FDA-approved — to the Committee of the Whole after hours of testimony from patients, physicians and policy advocates.
House Bill 25 12 70, which would let eligible patients pursue individualized investigational medical treatments that are not FDA-approved, was moved to the Committee of the Whole by the Senate Health and Human Services Committee with a favorable recommendation and placed on the consent calendar after unanimous support.
The bill’s sponsor, Senator Sandra Doherty, said the measure aims to complement existing federal and state pathways and to help patients with rare or rapidly progressing conditions who cannot wait for standard approval processes. "Both Right to Try and the proposed House Bill 12 70 work in tandem with long established and effective…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
